4//SEC Filing
Richard Robert E. 4
Accession 0000899243-22-006543
CIK 0001327273other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 9:30 PM ET
Size
9.6 KB
Accession
0000899243-22-006543
Insider Transaction Report
Form 4
Richard Robert E.
SVP of R&D
Transactions
- Award
Stock Option
2022-02-12+35,000→ 35,000 totalExercise: $4.78Exp: 2032-02-11→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following February 12, 2022.
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001816151
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 9:30 PM ET
- Size
- 9.6 KB